Inactive Instrument

News Evotec SE Other OTC

Equities

EVTCY

US30050E1055

Summary

Unlock all the news: Be the first to know and act before the market!

Evotec benefits modestly from research payment	06-12	DP
Evotec to Receive $20 Million Under Neuroscience Partnership with Bristol Myers Squibb	06-12	MT
Evotec Gets $20 Million Milestone Payment in Neurodegenerative Disease Collaboration With Bristol Myers Squibb	06-12	MT
Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb	06-12	CI
Evotec announces progress in neuroscience collaboration with Bristol Myers Squibb	06-12	EQ
Evotec : Presence and Voting Results AGM 2024 229.115 KB	06-11	PU
Evotec SE: Results of the Annual General Meeting 2024	06-10	EQ
EVOTEC : RBC remains its Buy rating	06-10	ZD
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	06-04	EQ
Evotec : Aurobac Therapeutics presents its R&D strategy & pipeline and announces new development program with Boehringer Ingelheim	06-03	PU
Evotec : and QIAGEN enter software collaboration for enhanced multi-omics data insights	06-03	PU
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	05-30	EQ
Evotec Partners With French Institutions, Company to Research Obesity	05-30	MT
Evotec Joins Collaboration to Identify New Therapies for Obesity, Metabolic Diseases	05-30	MT
Evotec, Inserm, Lille Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases	05-30	CI
Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases	05-30	EQ
Evotec : Update of the Declaration of Conformity with the German Corporate Governance Code for the Year 2023 (May 2024) 127.622 KB	05-29	PU
Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington's disease	05-29	AQ
Evotec Extends Drug Discovery Collaboration With CHDI Foundation for Huntington's Disease	05-28	MT
Evotec, CHDI Foundation Extend 20-year Partnership for Huntington's Disease Treatments	05-28	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Evotec SE Other OTC

Equities

EVTCY

US30050E1055

Summary

Filters